ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $222,147 | +5.3% | 5,477 | -10.3% | 0.00% | 0.0% |
| Q2 2022 | $211,000 | -24.1% | 6,104 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $278,000 | -38.2% | 6,104 | -8.6% | 0.00% | -50.0% |
| Q4 2021 | $450,000 | -40.6% | 6,678 | -45.0% | 0.00% | -42.9% |
| Q3 2021 | $758,000 | -0.3% | 12,144 | +32.4% | 0.01% | 0.0% |
| Q2 2021 | $760,000 | +7.0% | 9,173 | -14.3% | 0.01% | +40.0% |
| Q1 2021 | $710,000 | -40.6% | 10,700 | -31.4% | 0.01% | +25.0% |
| Q4 2020 | $1,196,000 | – | 15,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |